1 / 9

Chapter 86

Chapter 86. Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis. Aminoglycosides. Most commonly employed agents Gentamicin, tobramycin, amikacin Narrow-spectrum antibiotics Bactericidal Use – aerobic gram-negative bacilli Can cause serious injury to inner ear and kidney

rafi
Télécharger la présentation

Chapter 86

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chapter 86 Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis

  2. Aminoglycosides • Most commonly employed agents • Gentamicin, tobramycin, amikacin • Narrow-spectrum antibiotics • Bactericidal • Use – aerobic gram-negative bacilli • Can cause serious injury to inner ear and kidney • Not absorbed from the GI tract • Microbial resistance

  3. Aminoglycosides • Adverse effects • Nephrotoxicity • Ototoxicity • Hypersensitivity reactions • Neuromuscular blockade • Blood dyscrasias • Drug Interactions • Penicillins, cephalosporins and vancomycin, ototoxic drugs, nephrotoxic drugs, skeletal muscle relaxants

  4. Fig. 86-1. Structural formulas of the major aminoglycosides.

  5. Fig. 86-2. Mechanism of action of aminoglycosides. A, Protein synthesis begins with binding of the 50S and 30S ribosomal subunits to messenger RNA (mRNA), followed by attachment of the first amino acid of the new protein to the 50S subunit. As the ribosome moves down the mRNA strand, additional amino acids are added to the growing peptide chain. When the new protein is complete, it separates from the ribosome and the ribosomal subunits separate from the mRNA. B, Aminoglycosides bind to the 30S ribosomal subunit and can thereby (1) block initiation, (2) terminate synthesis before the new protein is complete, and (3) cause misreading of the genetic code, which causes synthesis of faulty proteins.

  6. Serum Levels • Dosing • Single large dose each day or 2-3 smaller doses • Monitoring of serum levels is common – the same aminoglycoside dose can produce very different plasma levels in different patients. • Peak levels must be high enough to kill bacteria; trough levels must be low enough to minimize toxicity.

  7. Gentamicin (Garamycin) • Used to treat serious infections caused by aerobic gram-negative bacilli • Pseudomonas aeruginosa • Escherichia coli • Klebsiella • Serratia • Proteus mirabilis • Adverse effects • Nephrotoxicity • Ototoxicity

  8. Fig. 86-3. Plasma gentamicin levels produced with once-daily doses versus divided doses. The curves depict plasma levels of gentamicin produced with (1) a single large dose administered once a day versus (2) the same daily total given as three smaller doses spaced 8 hours apart. Plasma levels with both regimens are high enough to produce good bactericidal effects. The shaded area indicates levels that are low enough to permit washout of the drug from vulnerable cells in the inner ear. Note that, with once-daily dosing, levels are in the washout range for over 12 hours, versus a total of only 6 hours when divided doses are used. As a result, ototoxicity is lower with the once-a-day schedule.

  9. Other Aminoglycosides • Tobramycin (Nebcin) • Amikacin (Amikin) • Neomycin • Kanamycin (Kantrex) • Streptomycin • Paromomycin (Humatin)

More Related